Stock CHAMPIONS ONCOLOGY INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Champions Oncology Inc OTC Bulletin Board

Equities

US15870P1093

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Champions Oncology Inc
Mar. 15 Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI
Mar. 13 Craig-Hallum Downgrades Champions Oncology to Hold From Buy MT

Chart calendar Champions Oncology Inc

feb852755c461f03003cb4b708a8e612.v8s1zE39QZ895r4OysS-mmXhMsVwk7gqNYnRyNnAPqk.-f5mnijQEtlYh448oI_80Ci5dbAD0MJaAdzgi7qfd83p_2WkK6kCrm6J_w~6bc1dae0a5562fddedda4145cd8f723f

Upcoming events on Champions Oncology Inc

2024-07-17 Q4 2024 Earnings Release (Projected)
2024-09-15 Q1 2025 Earnings Release (Projected)
2024-12-09 Q2 2025 Earnings Release (Projected)
2025-03-17 Q3 2025 Earnings Release (Projected)

Past events on Champions Oncology Inc

2024-03-12 04:30 pm Q3 2024 Earnings Call
2024-03-12 04:30 pm Q3 2024 Earnings Release
2023-12-12 04:30 pm Q2 2024 Earnings Call
2023-12-12 04:00 pm Q2 2024 Earnings Release
2023-10-18 Annual General Meeting
2023-09-25 Translational Oncology Symposium
2023-09-13 04:30 pm Q1 2024 Earnings Call
2023-09-13 04:00 pm Q1 2024 Earnings Release
2023-07-24 04:30 pm Q4 2023 Earnings Call
2023-07-24 04:00 pm Q4 2023 Earnings Release
2023-07-18 Japanese Association for Cancer Immunology Scientific Conference
2023-07-11 Tumor Models Scientific Conference
2023-03-15 04:30 pm Q3 2023 Earnings Call
2023-03-15 03:50 pm Q3 2023 Earnings Release
2022-12-13 04:30 pm Interim 2023 Earnings Call
2022-12-13 04:00 pm Interim 2023 Earnings Release
2022-10-19 Annual General Meeting
2022-09-08 04:30 pm Q1 2023 Earnings Call
2022-09-08 04:00 pm Q1 2023 Earnings Release
2022-07-21 04:30 pm FY 2022 Earnings Call

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		27,1
25,8
4.95%		32,1
31,7
1.46%		41,0
40,5
1.32%		49,1
48,9
0.34%		53,9
53,7
0.39%
48,8

EBITDA
Million USD		Released
Forecast
Spread 		0,88
0,79
11.03%		-1,02
0,88
-215.65%		1,52
1,18
28.55%		2,21
2,80
-21.04%		-2,16
-2,04
-5.94%
-6,56

EBIT
Million USD		Released
Forecast
Spread 		0,27
0,70
-61.43%		-1,80
0,23
-868.31%		0,34
0,54
-36.82%		0,61
1,32
-53.93%		-5,26
-4,71
-11.55%
-9,50

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,23
0,24
-3.95%		-1,85
0,35
-634.78%		0,41
0,60
-31.53%		0,58
1,34
-56.39%		-5,27
-4,69
-12.36%
-9,53

Net income
Million USD		Released
Forecast
Spread 		0,13
0,70
-81.71%		-1,98
0,29
-776.37%		0,33
0,84
-60.36%		0,55
1,23
-55.48%		-5,34
-4,46
-19.53%
0,00

EPS
USD		Released
Forecast
Spread 		0,01
0,06
-83.33%		-0,17
0,03
-780%		0,02
0,06
-66.67%		0,04
0,09
-52.94%		-0,39
-0,33
-18.18%
0,00

Announcement Date15/07/1927/07/2022/07/2121/07/2224/07/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		13,2
12,5
5.81%		12,9
12,7
1.21%		13,7
13,2
4.19%		14,3
13,9
2.42%		12,8
13,1
-2.74%		13,1
12,9
1.64%		12,6
13,1
-3.85%		11,6
12,8
-9.78%		12,0
13,5
-10.81%
12,7


13,1


13,3


13,5


13,7

EBITDA
Million USD		Released
Forecast
Spread 		1,19
0,77
54.86%		0,22
0,81
-72.63%		0,23
0,40
-43.78%		0,69
0,85
-19.67%		-1,52
0,07
-2396.97%		-1,75
-1,63
-7.37%		-1,67
-1,20
-38.82%		-1,42
-1,83
22.64%		-1,66
-0,31
-433.44%
-1,71


-0,82


-0,78


-0,42


-0,63

EBIT
Million USD		Released
Forecast
Spread 		0,83
0,45
84.31%		-0,31
0,40
-177.81%		-0,28
0,01
-2403.33%		0,01
-0,04
118.58%		-2,46
-0,57
-333%		-2,52
-1,98
-27.54%		-2,55
-1,74
-47.05%		-1,96
-2,36
17.21%		-2,58
-1,15
-124.09%
-2,42


-1,57


-1,48


-1,27


-1,36

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,80
0,46
73.98%		-0,35
0,41
-184.8%		-0,30
0,02
-1561.05%		0,00
-0,04
95.31%		-2,42
-0,57
-325.41%		-2,54
-1,96
-29.53%		-2,54
-1,71
-48.16%		-2,06
-2,35
12.2%		-2,52
-1,15
-120%
-2,41


-1,56


-1,47


-1,27


-1,35

Net income
Million USD		Released
Forecast
Spread 		0,79
0,42
86.05%		-0,34
0,34
-201.47%		-0,32
0,11
-394.01%		-0,02
-0,06
71.26%		-2,44
-0,44
-454.95%		-2,56
-1,69
-51.58%		-2,57
-1,41
-81.99%		-2,07
-2,30
9.88%

















EPS
USD		Released
Forecast
Spread 		0,05
0,03
100%		-0,02
0,03
-180%		-0,02
0,01
-300%		0,00
0,01
- 		-0,18
-0,04
-414.29%		-0,19
-0,13
-52%		-0,19
-0,10
-90%		-0,15
-0,17
11.76%

















Announcement Date15/03/2221/07/2212/09/2213/12/2215/03/2324/07/2313/09/2312/12/2312/03/24-----

Upcoming sector events for Champions Oncology Inc

Today 06:30 am UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
Today 06:30 am BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
Today 07:00 am ALKERMES PLC: Q1 2024 Earnings Release
2024-05-01 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
2024-05-01 CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 GALAPAGOS NV: Q1 2024 Earnings Release
2024-05-02 06:30 am MODERNA, INC.: Q1 2024 Earnings Release
More events

Past sector events for Champions Oncology Inc

Today DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
Today AZENTA, INC.: Q2 2024 Earnings Release (Projected)
2024-04-29 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-29 04:05 pm QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 04:01 pm MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-27 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CSBR Stock
  4. Stock
  5. Calendar Champions Oncology Inc